TherapeuticsMD, Inc. - FORM 8-K - EX-10.13 - RESIGNATION OF ROBERT CAMBRIDGE - February 18, 2011

Attached files

file filename
8-K - CURRENT REPORT - TherapeuticsMD, Inc.amhn-8k_0216.htm
EX-10.08 - CONSULTING AGREEMENT WITH BACK OFFICE CONSULTANTS, INC. - TherapeuticsMD, Inc.ex-10_08.htm
EX-10.12 - EXCLUSIVE LICENSING, DISTRIBUTION AND ADVERTISING SALES AGREEMENT - TherapeuticsMD, Inc.ex-10_12.htm
EX-10.09 - AGREEMENT, ACKNOWLEDGMENT AND CONSENT BETWEEN THE COMPANY AND SEATAC - TherapeuticsMD, Inc.ex-10_09.htm
EX-10.10 - JOINT DIRECTION TO RELEASE PLEDGED INTERESTS FROM ESCROW - TherapeuticsMD, Inc.ex-10_10.htm
EX-10.11 - TRADEMARK ASSIGNMENT AND AGREEMENT - TherapeuticsMD, Inc.ex-10_11.htm
 
Exhibit 10.13 – Resignation of Robert Cambridge



February 15, 2011



AMHN, Inc.
100 North First Street
Suite 104
Burbank, CA  91502

Effective immediately, please consider this letter my resignation as the sole officer and director of AMHN, Inc.  My resignation was not the result of a disagreement with the Company or any matter relating to the Company's operations, policies, or practices.

Sincerely,

/s/ Robert Cambridge                     

Robert Cambridge

TherapeuticsMD, Inc. Reports

Also read